메디케어에 등록된 류마티스 관절염 환자에서 생물학적 제제와 관련된 입원 감염의 비교 위험

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Risk of Hospitalized Bacterial Infections Associated With Biologic Treatment Among US Veterans With Rheumatoid Arthritis2014 · 102 citations
2. 2Initiation of Tumor Necrosis Factor-α Antagonists and the Risk of Hospitalization for Infection in Patients With Autoimmune Diseases2011 · 353 citations
3. 3Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial2003 · 1,764 citations
4. 4Role of disease risk scores in comparative effectiveness research with emerging therapies2012 · 109 citations
5. 5The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: Results of a phase IIB randomized, double‐blind, placebo‐controlled, dose‐ranging trial2006 · 1,059 citations